Biofilms, NETosis, and Microclots: Jim Hoffman Reflects on New Scientific Advances
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
” ‘Two key processes sustaining chronic infections are biofilm formation and NETosis. While NETs can immobilize and kill (planktonic) microbes, the extracellular DNA and associated proteins often contribute to biofilm stability, immune evasion, (antibiotic resistance), and chronic infection persistence. This review explores the bidirectional interactions between NETosis and biofilm formation, with a focus on their synergistic roles in the pathogenesis of chronic infections such as cystic fibrosis lung disease, diabetic foot ulcers, periodontitis, and implant-associated infections. Emerging therapeutic strategies aimed at disrupting this pathogenic interplay, including DNase-based treatments, PAD4 inhibitors, and combination therapies, are critically evaluated. By illuminating the pathogenic synergy between NETs and biofilms, this review underscores the need for integrated immunomodulatory and anti-biofilm interventions to effectively manage chronic infectious diseases and improve patient outcomes.’ (Tyagi et al 2025)
What is the potential relationship of biofilms to amyloid-like fibrinolytic-resistant microclots, recently reported on by Pretorius and Thierry et al 2025?
More importantly, can helping sick patients remove persistently elevated circulating NETs from their blood supply minimize immunothrombotic vasculitis injury and unwanted intravascular ischemic thrombi formation, which are characteristic of progressive severe life-threatening disseminated intravascular coagulation (Toh et al), regardless of the NETosis-triggering event, be it infectious or non-infectious in origin? Also, will removing chronically elevated NETs from the blood enhance the innate immune system’s ability to phagocytically target, clear, and digest NETotic biofilms from the tissues, and avert the potentially catastrophic consequences of septic shock and intravascular thrombi formation?
In addition, primary tumor cells and CTCs, like pathogens, have been observed to be similarly protected by extracellular NETosis-generated scaffolds, facilitating tumorigenesis, cancer-associated thrombosis, metastasis, and NETs are credited with greater resistance to existing anti-tumor therapies.”
Read more here.
Title: The Relationship Between NETosis and Biofilm Formation in Chronic Infections
Authors: Wafa Aziz, Hina Sultana, Vinay Kumar, Anuradha Tyagi
Stay updated with Hemostasis Today.
-
Jan 30, 2026, 11:38Aaron Rodriguez Calienes on Intracranial Stenting: Rescue vs First-Line Outcomes
-
Jan 30, 2026, 11:25Ahmed Nasreldein on Sex Disparities in Thrombolysis Delay Among Egyptian Stroke Patients
-
Jan 30, 2026, 11:17Yanki Yarman: My PhD Project Has Been Published in Blood!
-
Jan 30, 2026, 11:08Alexandros Apostolou on Complications Associated with IDU and Thrombophilia
-
Jan 30, 2026, 10:57Peisong Ma on GRK5 Polymorphism Affecting Platelets
-
Jan 30, 2026, 10:47Ashok Yadav Explains Fetal Thrombotic Vasculopathy: FTV
-
Jan 30, 2026, 10:34Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis